CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, today announced that CEO and Co-founder Dr. David Berry will present a company overview at the 21^st annual BioCentury Future Leaders in the Biotech Industry Conference.

Dr. Berry's presentation will focus on Seres' development of the first therapeutics that can catalyze a shift to health by augmenting the biology of the microbiome for the treatment of infectious, metabolic, and inflammatory diseases.

The presentation will take place on Friday, March 28, 2014 at 3:50 p.m. ET in presentation room 508 at the Millennium Broadway Hotel in New York City.

For more information on Seres Health please visit www.sereshealth.com

About Seres Health 

Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome.  Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome.  Current candidates span infectious, metabolic, and inflammatory diseases.  For more information, please visit www.sereshealth.com.

Contact:

For Seres Health            
Emily Rossi
Ruder Finn 
212.593.6431
flagship@ruderfinn.com

SOURCE Seres Health

RELATED LINKS
http://www.sereshealth.com